Aclarion, Inc.’s Quiet Period Set To End on June 1st (NASDAQ:ACON)

Aclarion’s (NASDAQ:ACON – Get Rating) quiet period will expire on Wednesday, June 1st. Aclarion had issued 2,165,000 shares in its initial public offering on April 22nd. The total size of the offering was $9,417,750 based on an initial share price of $4.35. During Aclarion’s quiet period, insiders and underwriters involved in the IPO are prevented from issuing any research reports or earnings estimates for the company because of SEC regulations. Following the expiration of the company’s quiet period, it’s expected that the brokerages that served as underwriters on the stock will initiate research coverage on the company.

Shares of Aclarion stock traded up $0.02 on Wednesday, hitting $1.28. 78,790 shares of the company traded hands, compared to its average volume of 2,259,848. Aclarion has a 12-month low of $1.16 and a 12-month high of $4.05.

About Aclarion (Get Rating)

Aclarion, Inc, a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software.

Featured Articles

• Get a free copy of the StockNews.com research report on Aclarion (ACON)
• The Analysts Like The Fit Of Victoria’s Secret & Co 
• Ambarella Is A Buy For Patient Investors 
• Don’t Bet On A Big Rebound For Salesforce.com Stock 
• 3 Specialty Retailers with Special Upside
• Is Roku (NASDAQ: ROKU) Bottoming Out?

Want More Great Investing Ideas?